Latest Breaking News On - Senior neurology analyst - Page 1 : vimarsana.com

GlobalData : TauRx s HMTM could become first oral DMT targeting Tau for Alzheimer s disease, says GlobalData -March 08, 2024 at 11:12 pm EST

08 Mar, 2024 TauRx s HMTM could become first oral DMT targeting Tau for Alzheimer s disease, says GlobalData Share Print.

United kingdomPhilippa salterInternational conference on alzheimerSenior neurology analystDrugs database

Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData

Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomEli lillyPippa salterMedicaid servicesInternational conference on alzheimerUs centers for medicareSenior neurology analystEisai partnered leqembi

Relmada Therapeutics anti-depressant - rapid and sustained effects

Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).

Philippa salterCedric ogormanSenior neurology analystRelmada therapeuticsAxsome therapeutic auvelityClinical developmentPreclinical researchAtient centricityPis active pharmaceutical ingredientsMajor depressive disorderAnti depressantClinical trialClinical studyClinical research

Could first anti-tau therapy be approved for Alzheimer s?

Could first anti-tau therapy be approved for Alzheimer s?
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Claude wischikPippa salterTaurx therapeuticSenior neurology analystProfessor claude wischik